Regeneten Patch vs Standard Care in Partial Thickness Rotator Cuff Repair

Last updated: December 14, 2020
Sponsor: Rothman Institute Orthopaedics
Overall Status: Active - Enrolling

Phase

N/A

Condition

Orthopedic Surgery

Orthopedics

Treatment

N/A

Clinical Study ID

NCT04673344
FTJO2020-0876
  • Ages 40-75
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Shoulder pain is a common complaint with the most common reason being tendinopathy and/or tearing of the rotator cuff. While many rotator cuff tears are often considered normal, age-related degenerative disorders, with either partial- or full-thickness rotator cuff tears evident in 4% of patients aged <40 years and in 54% of patients aged >60 years, once they become symptomatic and conservative management fails, they are typically repaired surgically. Data suggest that the incidence of surgery to repair and re-attach the cuff continues to rise. However, despite positive clinical results overall, reports of repair failure after surgery can range from 16%-94%, and of those that do fail, or fail to heal, generally do so within the first 3 to 6 months post-surgery.

Given the aforementioned reported issues with the gold standard for the treatment of unresponsive and symptomatic partial or full rotator cuff tears (surgical repair), together with the invasiveness of this surgery and lengthy period of restricted activity, other means of treatment have been proposed.

The REGENETEN scaffold/implant seeks to support new tendon growth and disrupt disease progression. This study seeks to investigate the outcome of surgical rotator cuff repair versus scaffold augmentation (using the REGENETEN scaffold) for symptomatic partial thickness rotator cuff tears.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Males and females aged 40-75 years with a partial-thickness rotator cuff tear (50% ormore) confirmed on MRI scan that, in combination with patient-report symptoms andclinical examination by the orthopaedic surgeon, would confirm the rotator cuff tearas the primary pathology driving pain, symptoms and functional disability .
  • Symptoms > 3 months
  • Unsuccessful conservative treatment comprising of a corticosteroid injection (into thesubacromial bursa) and physiotherapy (while it is acknowledged that a range ofmodalities may be available to patient's presenting with apparent symptomatic rotatorcuff pathology, for the current study, physiotherapy has been defined specifically asa course of 'exercise-based' therapy specific to the individual patient, thoughgenerally comprising of exercises designed to strengthen the rotator cuff and scapulastabilizing musculature, improving flexibility and shoulder mobility)

Exclusion

Exclusion Criteria:

  • Revision surgery
  • Cervical pathology
  • Adhesive capsulitis
  • Multi-tendon tears
  • Concomitant upper limb pathology (eg: arthritis, nerve compression)
  • Infection
  • Previous fracture
  • Instability
  • Pregnancy and lactation
  • Professional athlete
  • Worker's compensation or compensable claim
  • Substance abuse or current mental illness
  • Smoker
  • Adverse reaction to bovine derived products

Study Design

Total Participants: 80
Study Start date:
December 30, 2020
Estimated Completion Date:
December 31, 2021

Connect with a study center

  • Rothman Orthopaedic Institute

    Philadelphia, Pennsylvania 19107
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.